Through the heat of the pandemic in 2020, FIDSON’s revenue maintained a robust growth trajectory- a reflection of the essential nature of the firm’s products. So far, in 2021, the firm has recorded even stronger performances across major line items. In the first half, revenue from both business units-Ethical and Over-the-counter (OTC)- expanded year on year against the backdrop of improved sales volume and increased price on select products. The Ethical unit registered a top-line growth of 72.41% YoY to NGN8.10bn from NGN4.70bn in H1:2020. The sales from OTC products also leaped by 36.74% YoY to NGN4.79bn during the half-year period. An assessment of the firm’s quarterly performance reveals a 47.64% revenue growth in the second quarter to NGN6.57bn in Q2:2021 (a significant milestone for the firm) from NGN4.45bn in Q2:2020.
Kindly use the link below to download the full report
